IRIX: the cashflow

MyFinsight

For the quarter ending 2025-09-27, IRIX had -$1,205K decrease in cash & cash equivalents over the period. -$1,171K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-27	2025-06-28
Net loss	-1,573	-2,680
Loss on inventory write-down	823	-
Loss on extinguishment of convertible note payable	0	-1,335
Depreciation and amortization	110	262
Amortization of operating lease right-of-use assets	256	497
Accretion of original issue discount	0	-58
Amortization of debt issuance costs	30	109
Stock-based compensation	92	470
Accounts receivable	-5	1,186
Receivable from related party	-495	450
Inventories	-311	-2,382
Prepaid expenses and other current assets	37	-339
Other long-term assets	-77	-121
Accounts payable	-905	-2,025
Payable to related party	-222	-174
Accrued compensation	71	189
Accrued expenses	8	107
Deferred revenue	-440	-670
Operating lease liabilities	-313	-512
Other liabilities	54	282
Net cash used in operating activities	-1,158	-1,546
Acquisition of property and equipment	13	24
Net cash used in investing activities	-13	-24
Proceeds from issuance of convertible note payable	0	4,000
Cash paid for debt issuance costs	0	-
Proceeds for stock options exercise	0	-
Payments on convertible note payable	0	3,961
Proceeds from issuance of series b convertible preferred stock	0	6,000
Taxes paid related to net share settlements of equity awards	34	14
Net cash provided by financing activities	-34	6,025
Effect of foreign exchange rate changes	0	-64
Net increase (decrease) in cash and cash equivalents	-1,205	4,391
Cash and cash equivalents at beginning of period	2,387	-
Cash and cash equivalents at end of period	5,573	-

Unit: Thousand (K) dollars